Talphera (TLPH) Capital Expenditures (2011 - 2023)
Talphera's (TLPH) quarterly Capital Expenditures came in at $100000.0 in Q1 2023, up 12.36% year-on-year from $89000.0 in Q1 2022, and up 108.33% quarter-over-quarter from $48000.0 in Q4 2022.
Talphera (TLPH) Capital Expenditures (2011 - 2023) Analysis & Trends
Talphera's Capital Expenditures history runs 13 years deep, the most recent figure standing at $100000.0 for Q1 2023.
- On a quarterly basis, Capital Expenditures rose 12.36% year-over-year to $100000.0 in Q1 2023; TTM through Dec 2023 was $100000.0, a 72.53% decrease from a year earlier, with the FY2023 full-year figure at $100000.0, down 72.53% from the prior year.
- Capital Expenditures climbed to $100000.0 in Q1 2023 per TLPH's latest filing, from $48000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.6 million in Q4 2020 and bottomed at $24000.0 in Q1 2021.
- The 5-year median for Capital Expenditures is $100000.0 (2023), against an average of $448000.0.
- Biggest YoY gain for Capital Expenditures was 1540.21% in 2021; the steepest drop was 98.28% in 2021.
- Year by year, Capital Expenditures stood at $242000.0 in 2019, then jumped by 573.97% to $1.6 million in 2020, then slumped by 98.28% to $28000.0 in 2021, then jumped by 71.43% to $48000.0 in 2022, then surged by 108.33% to $100000.0 in 2023.
- Per Business Quant, the three latest TLPH Capital Expenditures figures stand at $100000.0 (Q1 2023), $48000.0 (Q4 2022), and $158000.0 (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 48,000.00 |
| Dec 31, 2022 | 48,000.00 |
| Sep 30, 2022 | 158,000.00 |
| Sep 30, 2022 | 158,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Mar 31, 2022 | 89,000.00 |
| Mar 31, 2022 | 89,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 184,000.00 |
| Sep 30, 2021 | 184,000.00 |
| Jun 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Mar 31, 2021 | 24,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Dec 31, 2020 | 1.63 Mn |
| Dec 31, 2020 | 1.63 Mn |